CareDx, Inc (CDNA) jumped $1.56 to $26.11 on over $1 million shares traded Wednesday, more than 1 1/2 times its average volume. The transplant diagnostics company is scheduled to report third quarter results on November 8. The move popped the stock out of a month-long coiling pattern. A move through the October 1 high near $19.50 could accelerate the stock towards the channel top in the high-$30's.

FireEye, Inc. (FEYE) leapt $1.64 to $18.49 Wednesday on huge volume of 18 million shares, 3 1/2 times its average volume. The cybersecurity company released better-than-expected third quarter results after the close Tuesday. The stock appears to be emerging out of a multi-year basing pattern. Resistance is at the April high of $19.36. A move through that could get the stock towards the channel top at around $22.

Tandem Diabetes Care, Inc. (TNDM) rose $2.92 to $37.61 Wednesday on 2.2 million shares. The developer of insulin delivery systems is scheduled to report after the close today. Wednesday's move broke the stock above the declining tops line from its pullback off the September high. The stock faces next lateral resistance just above here at $37.70, and then minor resistance at $40.50, a move through which could accelerate it higher.

Xilinx, Inc. (XLNX) gained $3.32 to $85.37 Wednesday on 5.7 million shares, more than twice its average volume. The maker of programmable chips reported better-than-expected earnings last Wednesday, and also has reportedly won orders from Microsoft Corp.’s Azure cloud unit. The move broke the stock out above recent highs from early October, positioning it for a move next towards the rising channel top near $92.

See Harry's video chart analysis on these stocks.

No holdings.

Harry

Harry Boxer is founder of TheTechTrader.com, a live trading room featuring his stock picks, technical market analysis, and live chart presentations.

(c) 2018 AdviceTrade, Inc. All rights reserved. Distributed o7nly by written permission of AdviceTrade and The Technical Trader at info@advicetrade.com . In using any portion of Harry Boxer's content, you agree to the terms and conditions governing the use of the service as described in our disclaimer at http://www.thetechtrader.com

Mr. Boxer's commentaries and index analysis represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Trades mentioned on the site are hypothetical, not actual, positions.

Harry Boxer Archive

Only logged in users are allowed to post comments. Register/ Log in

The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2024 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any other financial instrument at any time. We recommend that independent professional advice is obtained before you make any investment or trading decisions. By using this site you agree to this sites Terms of Use. From time to time we promote or endorse certain products / services that we believe are worthy of your time and attention. In return for that endorsement and only in the cases where you purchase directly though us may we be compensated by the producers of those products.